According to the latest disclosure from the Hong Kong Stock Exchange, BlackRock increased its shareholding in INNOVENT BIO (01801) on August 12, acquiring 139,500 shares at a price of HKD 95.375 per share.
The total transaction value amounted to approximately HKD 13.30 million. Following this purchase, BlackRock's latest shareholding count stands at approximately 87.32 million shares, representing a 5.01% stake in the company.